Genta Incorporated

Quick facts

Phase 1 pipeline

• G3139, Oblimersen sodium, Bcl-2 antisense oligonucleotide
• Genasense followed by DTIC; then DTIC alone

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Genta Incorporated portfolio CI brief
• Genta Incorporated pipeline updates RSS